For years, a quiet fear has shadowed pregnant women who depend on antidepressants: that in treating their own suffering, they might somehow shape the neurology of the child they carry. A sweeping meta-analysis published in The Lancet Psychiatry, drawing on data from more than 600,000 medicated pregnancies, now offers a measured but meaningful reassurance — the medications themselves are not the cause. What the data reveal instead is the deeper story of inheritance and family circumstance, reminding us that the roots of human development are rarely found in a single variable.
Meta-analysis finds no causal link between pregnancy antidepressants and autism
Cobertura Relacionada
Mark Zuckerberg y su esposa compraron Strancally Castle, una propiedad neogótica de 1830 en Waterford, Irlanda, valorada…
Cadena SER · Aug 21 Las gafas inteligentes de Meta se prohíben en Reino Unido por preocupaciones de privacidadLas gafas inteligentes de Meta están siendo prohibidas en tribunales, pubs y teatros del Reino Unido por preocupaciones …
Infobae · Aug 21 GIGABYTE AORUS lanza en Argentina su notebook gamer más potente con Ryzen 9 y RTX 5090GIGABYTE AORUS presenta en Argentina la AORUS MASTER 16 (Gen 2), una notebook gamer de gama alta equipada con procesador…
EL UNIVERSAL · Aug 21 Apple Maps despliega caminantes con cámaras 360° para cartografiar zonas inaccesiblesApple financia a personas equipadas con cámaras de 360 grados y GPS para cartografiar áreas inaccesibles a vehículos, me…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
Medical research finding no causal link between pregnancy antidepressants and autism has no geopolitical implications; this is a public health science article.
Lente Econômica
Meta-analysis of 600,000+ pregnancies finds no causal link between common antidepressants and autism/ADHD, reducing liability risks for pharmaceutical companies and potentially increasing medication adherence among pregnant women.
Pregnant women with depression/anxiety gain reassurance to continue antidepressant treatment without fear of causing neurodevelopmental disorders in offspring, improving maternal mental health outcomes and reducing treatment discontinuation.
Regulatory bodies may update pregnancy safety labeling for antidepressants, potentially reducing warning labels and litigation risk. Healthcare systems may expand mental health coverage for pregnant women. Reduced need for expensive autism/ADHD diagnostic testing and interventions if preventable causes are eliminated.